-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q2 2023.
- RVL Pharmaceuticals plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 99.4M shares, a 18.9% increase year-over-year.
- RVL Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 89.8M shares, a 33.3% increase from 2021.
- RVL Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 67.4M shares, a 11% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)